A Win For InMed Pharmaceuticals Inc.
Mon, Sep 12, 2022 at 07:39 PM
InMed Pharmaceuticals Inc. (INM:NASDAQ) soared at $18.78, a gain of 70.4%. On Mon, Sep 12, 2022, INM:NASDAQ hit a New 2-Week High of $18.78. The stock got featured on our News Catalysts scanner on Fri, Sep 09, 2022 at 06:05 PM in the 'PRIVATE PLACEMENT' category. From Mon, Aug 29, 2022, the stock recorded 77.78% Up Days and 40.00% Green Days
About InMed Pharmaceuticals Inc. (INM:NASDAQ)
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company.
Top 10 Gainers:
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 101.3%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 70.42%
- Ventyx Biosciences Inc. (VTYX:NASDAQ), 64.98%
- PolyPid Ltd. (PYPD:NASDAQ), 58.33%
- Arqit Quantum Inc. (ARQQ:NASDAQ), 38.1%
- PaxMedica Inc. (PXMD:NASDAQ), 36.59%
- IDEAYA Biosciences, Inc. (IDYA:NASDAQ), 30.7%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 30.43%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 27.68%
- IHS Holding Limited (IHS:NYSE), 24.88%